Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA).
BMJ Open
; 11(5): e050682, 2021 05 05.
Article
in En
| MEDLINE
| ID: mdl-33952559
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ductus Arteriosus, Patent
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
Aspects:
Ethics
Limits:
Humans
/
Infant
/
Newborn
Country/Region as subject:
America do norte
Language:
En
Journal:
BMJ Open
Year:
2021
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido